Literature DB >> 18945391

New biomedical strategies for HIV-1 prevention in women.

Jared M Baeten1.   

Abstract

Novel HIV-1 prevention strategies continue to be urgently needed. This article reviews the current state of biomedical prevention against HIV-1, focusing on recently completed and ongoing clinical trials of new prevention interventions, particularly those relevant to prevention of HIV-1 in women. Male circumcision, cervical barrier devices, suppressive therapy against herpes simplex virus type 2, treatment of vaginal infections and other vaginal health interventions, pre-exposure antiretroviral prophylaxis, and topical vaginal microbicides are discussed.

Entities:  

Year:  2008        PMID: 18945391     DOI: 10.1007/s11908-008-0080-1

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  42 in total

Review 1.  Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: epidemiological evidence and biological mechanisms.

Authors:  Landon Myer; Louise Kuhn; Zena A Stein; Thomas C Wright; Lynette Denny
Journal:  Lancet Infect Dis       Date:  2005-12       Impact factor: 25.071

2.  Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda.

Authors:  Rebecca Bunnell; John Paul Ekwaru; Peter Solberg; Nafuna Wamai; Winnie Bikaako-Kajura; Willy Were; Alex Coutinho; Cheryl Liechty; Elizabeth Madraa; George Rutherford; Jonathan Mermin
Journal:  AIDS       Date:  2006-01-02       Impact factor: 4.177

Review 3.  Vaginal microbicides: moving ahead after an unexpected setback.

Authors:  Janneke Hhm van de Wijgert; Robin J Shattock
Journal:  AIDS       Date:  2007-11-30       Impact factor: 4.177

4.  Reassessing the hypothesis on STI control for HIV prevention.

Authors:  Ronald H Gray; Maria J Wawer
Journal:  Lancet       Date:  2008-06-21       Impact factor: 79.321

5.  Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial.

Authors:  Lut Van Damme; Gita Ramjee; Michel Alary; Bea Vuylsteke; Verapol Chandeying; Helen Rees; Pachara Sirivongrangson; Léonard Mukenge-Tshibaka; Virginie Ettiègne-Traoré; Charn Uaheowitchai; Salim S Abdool Karim; Benoît Mâsse; Jos Perriëns; Marie Laga
Journal:  Lancet       Date:  2002-09-28       Impact factor: 79.321

6.  New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data.

Authors:  Kristin L Dunkle; Rob Stephenson; Etienne Karita; Elwyn Chomba; Kayitesi Kayitenkore; Cheswa Vwalika; Lauren Greenberg; Susan Allen
Journal:  Lancet       Date:  2008-06-28       Impact factor: 79.321

7.  Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes.

Authors:  J Kreiss; E Ngugi; K Holmes; J Ndinya-Achola; P Waiyaki; P L Roberts; I Ruminjo; R Sajabi; J Kimata; T R Fleming
Journal:  JAMA       Date:  1992 Jul 22-29       Impact factor: 56.272

8.  Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics.

Authors:  Esther E Freeman; Kate K Orroth; Richard G White; Judith R Glynn; Roel Bakker; Marie-Claude Boily; Dik Habbema; Anne Buvé; Richard Hayes
Journal:  Sex Transm Infect       Date:  2007-04-03       Impact factor: 3.519

9.  SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana.

Authors:  Leigh Peterson; Kavita Nanda; Baafuor Kofi Opoku; William Kwabena Ampofo; Margaret Owusu-Amoako; Andrew Yiadom Boakye; Wes Rountree; Amanda Troxler; Rosalie Dominik; Ronald Roddy; Laneta Dorflinger
Journal:  PLoS One       Date:  2007-12-19       Impact factor: 3.240

10.  Risk compensation is not associated with male circumcision in Kisumu, Kenya: a multi-faceted assessment of men enrolled in a randomized controlled trial.

Authors:  Christine L Mattson; Richard T Campbell; Robert C Bailey; Kawango Agot; J O Ndinya-Achola; Stephen Moses
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

View more
  3 in total

Review 1.  Drug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug delivery.

Authors:  Minlu Hu; Sravan Kumar Patel; Tian Zhou; Lisa C Rohan
Journal:  J Control Release       Date:  2015-08-13       Impact factor: 9.776

2.  Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies.

Authors:  Renee Heffron; Kenneth Ngure; Nelly Mugo; Connie Celum; Ann Kurth; Kathryn Curran; Jared M Baeten
Journal:  J Acquir Immune Defic Syndr       Date:  2012-09-01       Impact factor: 3.731

3.  Advances in the prevention of heterosexual transmission of HIV/AIDS among women in the United States.

Authors:  Nadine E Chen; Jaimie P Meyer; Sandra A Springer
Journal:  Infect Dis Rep       Date:  2011-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.